Table 3 Indicative charting form

Citation details (e.g. author; country; year)

Setting/context (e.g. clinical- or population-based)

Population characteristics (e.g. age, sex, psychiatric comorbidity)

Methods (e.g. study design/method)

Assessment of PD/psychiatric comorbidity (e.g. diagnostic interview; DSM-5)

Assessment of MSDs (e.g. osteoporosis; identified by physician)

Indicator of disease burden (e.g. DALYs)

Key results (e.g. ORs/IRR according to each relevant concept/outcome; adjusted/unadjusted models noted)

Summary of key findings (e.g. description of the key findings)

Study limitations (e.g. reported by authors or otherwise identified)

Identified knowledge gaps (e.g. reported by authors or otherwise identified)

Recommendation for future research (e.g. reported by authors or otherwise identified)